{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:20:07Z","timestamp":1790886007260,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL071207"],"award-info":[{"award-number":["R01 HL071207"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GGP13107"],"award-info":[{"award-number":["GGP13107"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Telethon-Italy"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ppc-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Pediatric Cardiology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ppedcard.2015.01.002","type":"journal-article","created":{"date-parts":[[2015,1,31]],"date-time":"2015-01-31T04:31:00Z","timestamp":1422678660000},"page":"13-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Cardiomyopathies in Noonan syndrome and the other RASopathies"],"prefix":"10.1016","volume":"39","author":[{"given":"Bruce D.","family":"Gelb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ppedcard.2015.01.002_bb0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","article-title":"Noonan syndrome","volume":"381","author":"Roberts","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0010","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0015","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/hrt.68.12.586","article-title":"Myocardial disarray in Noonan syndrome","volume":"68","author":"Burch","year":"1992","journal-title":"Br Heart J"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1747-0803.2010.00465.x","article-title":"Survival implications: hypertrophic cardiomyopathy in Noonan syndrome","volume":"6","author":"Hickey","year":"2011","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0025","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2012.04.018","article-title":"Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry","volume":"164","author":"Wilkinson","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/adc.2006.104547","article-title":"The natural history of Noonan syndrome: a long-term follow-up study","volume":"92","author":"Shaw","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0035","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.amjcard.2007.03.093","article-title":"Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome","volume":"100","author":"Limongelli","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0040","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ajmg.a.33857","article-title":"Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: a Ras\/MAPK pathway syndrome","volume":"155A","author":"Lin","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0045","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1442-200X.1998.tb02000.x","article-title":"An infant with Costello syndrome complicated with fatal hypertrophic obstructive cardiomyopathy","volume":"40","author":"Tomita","year":"1998","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0050","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/jmg.2006.042796","article-title":"The cardiofaciocutaneous syndrome","volume":"43","author":"Roberts","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajmg.a.10923","article-title":"Noonan-like syndrome with loose anagen hair: a new syndrome?","volume":"118A","author":"Mazzanti","year":"2003","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0060","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/ajmg.a.36098","article-title":"Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: structural brain anomalies and myelofibrosis","volume":"161","author":"Gripp","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0065","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/jhg.2010.116","article-title":"Mutation analysis of the SHOC2 gene in Noonan-like syndrome and in hematologic malignancies","volume":"55","author":"Komatsuzaki","year":"2010","journal-title":"J Hum Genet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0070","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1002\/ajmg.a.36255","article-title":"GH Therapy and first final height data in Noonan-like syndrome with loose anagen hair (Mazzanti syndrome)","volume":"161A","author":"Mazzanti","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0075","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.425","article-title":"Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair","volume":"41","author":"Cordeddu","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0080","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/humu.20005","article-title":"Noonan syndrome-associated SHP2\/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2\/MAPK1 activation","volume":"23","author":"Fragale","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1749-6632.2010.05790.x","article-title":"Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms","volume":"1214","author":"Tartaglia","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/341528","article-title":"Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene","volume":"71","author":"Digilio","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0100","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/jmg.39.8.571","article-title":"PTPN11 mutations in LEOPARD syndrome","volume":"39","author":"Legius","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/499925","article-title":"Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease","volume":"78","author":"Tartaglia","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0110","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.M513068200","article-title":"PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects","volume":"281","author":"Kontaridis","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0115","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.febslet.2006.03.088","article-title":"Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1","volume":"580","author":"Hanna","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0120","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/ng1641","article-title":"Germline mutations in HRAS proto-oncogene cause Costello syndrome","volume":"37","author":"Aoki","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0125","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/340847","article-title":"PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity","volume":"70","author":"Tartaglia","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0130","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/humu.21492","article-title":"SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations","volume":"32","author":"Lepri","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0135","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0140","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng2078","article-title":"Germline gain-of-function mutations in RAF1 cause Noonan syndrome","volume":"39","author":"Razzaque","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ajhg.2013.05.021","article-title":"Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS\/MAPK pathway syndrome","volume":"93","author":"Aoki","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0150","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ajmg.a.33884","article-title":"Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C","volume":"155A","author":"Gripp","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajmg.c.30295","article-title":"Cardio-facio-cutaneous syndrome: does genotype predict phenotype?","volume":"157C","author":"Allanson","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0160","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/ajmg.a.35292","article-title":"Prevalence and clinical features of Costello syndrome and cardio-facio-cutaneous syndrome in Japan: findings from a nationwide epidemiological survey","volume":"158A","author":"Abe","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0165","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1172\/JCI44929","article-title":"MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation","volume":"121","author":"Wu","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0170","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1172\/JCI43910","article-title":"Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome-associated Sos1 mutation","volume":"120","author":"Chen","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0175","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI44972","article-title":"Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation","volume":"121","author":"Marin","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0180","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/MCB.00646-09","article-title":"Functional effects of PTPN11 (SHP2) mutations causing LEOPARD syndrome on epidermal growth factor-induced phosphoinositide 3-kinase\/AKT\/glycogen synthase kinase 3beta signaling","volume":"30","author":"Edouard","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0185","first-page":"2169","article-title":"A mouse model for Costello syndrome reveals an Ang II-mediated hypertensive condition","volume":"118","author":"Schuhmacher","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0190","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ng.2963","article-title":"RAF1 mutations in childhood-onset dilated cardiomyopathy","volume":"46","author":"Dhandapany","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.ppedcard.2015.01.002_bb0195","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/nn.3863","article-title":"Mechanism and treatment for learning and memory deficits in mouse models of Noonan syndrome","volume":"17","author":"Lee","year":"2014","journal-title":"Nat Neurosci"}],"container-title":["Progress in Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105898131500003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105898131500003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T19:05:49Z","timestamp":1717700749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105898131500003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S105898131500003X"],"URL":"https:\/\/doi.org\/10.1016\/j.ppedcard.2015.01.002","relation":{},"ISSN":["1058-9813"],"issn-type":[{"value":"1058-9813","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiomyopathies in Noonan syndrome and the other RASopathies","name":"articletitle","label":"Article Title"},{"value":"Progress in Pediatric Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ppedcard.2015.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}